Pre-diagnostic urinary 15-F2t-isoprostane level and liver cancer risk: Results from the Shanghai Women's and Men's Health Studies
International Journal of Cancer Sep 07, 2018
Ma X, et al. - Assuming that the oxidative stress affects cancer development via various mechanisms, researchers determined the level of 15-F2t-isoprostane (15-F2t-IsoP: an accurate marker of oxidative stress in humans) by enzyme-linked immunosorbent assay in the pre-diagnosis urine samples, collected at cohort enrollment, from 363 incident liver cancer cases and 725 individually matched controls to ascertain the correlation between urinary 15-F2t-IsoP level and cancer risk. Findings revealed a positive association between a high urinary 15-F2t-IsoP level and high liver cancer risk, suggesting that 15-F2t-IsoP may be a promising biomarker for liver cancer risk. Results thus suggest giving a higher priority to people with sero-positive HBsAg and higher level of 15-F2t-IsoP on future surveillance program of liver cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries